Role of dopamine receptors in normal and tumoral pituitary corticotropic cells and adrenal cells

Neuroendocrinology

Volumn 92, Issue SUPPL. 1, 2010, Pages 17-22

  Boschetti, Mara ^a   Gatto, Federico ^a   Arvigo, Marica ^a   Esposito, Daniela ^a   Rebora, Alberto ^a   Talco, Miryam ^a   Albertelli, Manuela ^a   Nazzari, Elena ^a   Goglia, Umberto ^a   Minuto, Francesco ^a   Ferone, Diego ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

Adrenal; Adrenal carcinoma; Chimeric molecules; Cushing's syndrome; Dopamine receptors; Hypercortisolism; Pituitary

Indexed keywords

DOPAMINE RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; G PROTEIN COUPLED RECEPTOR;

ADRENAL CELL; ADRENAL CORTEX CARCINOMA; CONFERENCE PAPER; CORTICOTROPIN RELEASE; CUSHING SYNDROME; ECTOPIC CORTICOTROPIN PRODUCTION; HORMONAL REGULATION; HORMONE RECEPTOR INTERACTION; HUMAN; HYPERCORTISOLISM; HYPOPHYSIS CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADRENAL CORTEX; ADRENAL CORTEX NEOPLASMS; CORTICOTROPHS; CUSHING SYNDROME; HUMANS; PITUITARY GLAND; PITUITARY NEOPLASMS; RECEPTORS, DOPAMINE;

EID: 77956545748     PISSN: 00283835     EISSN: None     Source Type: Journal    
DOI: 10.1159/000314293     Document Type: Conference Paper

References (20)

1. Pivonello R, Ferone D, Lombardi G, Colao A, Lamberts SW, Hofland LJ: Novel insights in dopamine receptor physiology. Eur J Endo-crinol 2007; 156(suppl 1):S13-S21.
2. Van Tol HH, Wu CM, Guan HC, Ohara K, Bunzow JR, Civelli O, Kennedy J, Seeman P, Niznik HB, Jovanovic V: Multiple dopamine D4 receptor variants in the human population. Nature 1992; 358: 14 9-1 5 2.
3. Wu KD, Chen YM, Chu TS, Chueh SC, Wu MH, Bor-Shen H: Expression and localization of huma n dopa m i ne D2 a nd D4 re c eptor mRNA in the adrenal gland, aldosterone-producing adenoma, and pheochromocyto-ma. J Clin Endocrinol Metab 2001; 86: 4460-4467.
4. Saiardi A, Borrelli E: Absence of dopaminer-gic control on melanotrophs leads to Cush-ing's-like syndrome in mice. Mol Endocrinol 1998; 12:1133-1139.
5. De Bruin C, Feelders RA, Lamberts SW, Hofland LJ: Somatostatin and dopamine receptors as targets for medical treatment of Cushing's syndrome. Rev Endocr Metab Disord 2009; 10:91-102.
6. De Bruin C, Meij BP, Kooistra HS, Hanson JM, Lamberts SW, Hofland LJ: Cushing's disease in dogs and humans. Horm Res 2009; 71(suppl 1):140-143.
7. Pivonello R, Ferone D, De Herder WW, Kros JM, De Caro ML, Arvigo M, Annunziato L, Lombardi G, Colao A, Hofland LJ, Lamberts SW: Dopamine receptor expression and function in corticotroph pituitary tumors. J Clin Endocrinol Metab 2004; 89:2452-2462. (Pubitemid 38619889)
8. Pivonello R, Ferone D, De Herder WW, De Krijger RR, Waaijers M, Mooij DM, Van Koetsveld PM, Barreca A, De Caro ML, Lombardi G, Colao A, Lamberts SW, Hof-land LJ: Dopamine receptor expression and function in human normal adrenal gland and adrenal tumors. J Clin Endocrinol Metab 2004; 89:4493-4502. (Pubitemid 39244461)
9. Pivonello R, Ferone D, De Herder WW, Fag-giano A, Bodei L, De Krijger RR, Lombardi G, Colao A, Lamberts SW, Hofland LJ: Do-pamine receptor expression and function in corticotroph ectopic tumors. J Clin Endocri-nol Metab 2007; 92:65-69.
10. Pivonello R, Ferone D, Lamberts SW, Colao A: Cabergoline plus lanreotide for ectopic Cushing's syndrome. N Eng l J Med 2005; 352: 2457-2458.
11. Ferone D, Gatto F, Arvigo M, Resmini E, Boschetti M, Teti C, Esposito D, Minuto F: The clinical-molecular interface of soma-tostatin, dopamine and their receptors in pituitary pathophysiology. J Mol Endocrinol 2009; 42:361-370.
12. De Bruin C, Feelders RA, Waaijers AM, Van Koetsveld PM, Sprij-Mooij DM, Lamberts SW, Hofland LJ: Differential regulation of human dopamine D2 and somatostatin receptor subtype expression by glucocorti-coids in vitro. J Mol Endocrinol 2009; 42:47-56.
13. De Bruin C, Pereira AM, Feelders RA, Rom-ijn JA, Roelfsema F, Sprij-Mooij DM, Van Aken MO, Van Der Lelij AJ, De Herder WW, Lamberts SW, Hofland LJ: Coexpression of dopamine and somatostatin receptor subtypes in corticotroph adenomas. J Clin En-docrinol Metab 2009; 94: 1118-11 2 4.
14. Petrossians P, Ronci N, Valdes SH, Kalife A, Stevenaert A, Bloch B, Tabarin A, Beckers A: ACTH silent adenoma shrinking under cab-ergoline. Eur J Endocrinol 2001; 14 4: 51-5 7.
15. Rocheville M, Lange DC, Kumar U, Patel SC, Patel RC, Patel YC: Receptors for dopamine and somatostatin: formation of hetero-oligomers with enhanced functional activity. Science 2000; 288:154-157.
16. Ferone D, Saveanu A, Culler MD, Arvigo M, Rebora A, Gatto F, Minuto F, Jaquet P: Novel chimeric somatostatin analogs: facts and perspectives. Eur J Endocrinol 20 07; 156(suppl 1):S23-S28.
17. Saveanu A, Gunz G, Guillen S, Dufour H, Culler MD, Jaquet P: Somatostatin and do-pamine-somatostatin multiple ligands directed towards somatostatin and dopamine receptors in pituitary adenomas. Neuroen-docrinology 2006; 83: 258-263.
18. Ferone D, Arvigo M, Semino C, Jaquet P, Saveanu A, Taylor JE, Moreau JP, Culler MD, Albertelli M, Minuto F, Barreca A: Soma-tostatin and dopamine receptor expression in lung carcinoma cells and effects of chime-ric somatostatin-dopamine molecules on cell proliferation. Am J Physiol Endocrinol Metab 2005; 289:E1044-E1050.
19. Chang HW, Chu TS, Huang HY, Chueh SC, Wu VC, Chen YM, Hsieh BS, Wu KD: Down-regulation of D2 dopamine receptor and increased protein kinase Cmu phosphoryla-tion in aldosterone-producing adenoma play roles in aldosterone overproduction. J Clin Endocrinol Metab 2007; 92:1863-1870.
20. Ferone D, Pivonello R, Resmini E, Boschetti M, Rebora A, Albertelli M, Albanese V, Co-lao A, Culler MD, Minuto F: Preclinical and clinical experiences with the role of dopa-mine receptors in the treatment of pituitary adenomas. Eur J Endocrinol 2007; 156(suppl 1): S37-S 4 3.